Red blood cell polyagglutination: clinical aspects.
Polyagglutination is the term applied to red blood cells (RBCs) that are agglutinated by almost all samples of human sera from adults but not by autologous serum or sera of newborns. The polyagglutinable state may be transient or persistent. Transient polyagglutinability results from the exposure of normally cryptic antigens by bacterial enzymatic activity during the course of an infectious process. RBCs are polyagglutinable because most sera from adults contain agglutinins for the exposed antigens. This type of polyagglutination can often be reproduced in vitro with bacterial culture fluids or isolated enzymes. Persistent polyagglutination may be a consequence of somatic mutation leading to a cellular lineage characterized by an enzyme deficiency that results in exposure of a normally cryptic antigen, Tn. Most human sera contain anti-Tn. Tn polyagglutination is regularly accompanied by leukopenia and thrombocytopenia and has been associated with leukemia. Other forms of persistent polyagglutination are due to the inheritance of rare blood groups or are associated with a hematologic dyscrasia.
Beck
M L
ML
Community Blood Center of Greater Kansas City, MO 64111, USA.
D000818:Animals; D001424:Bacterial Infections / Q000097:blood / Q000150:complications / Q000503:physiopathology; D006384:Hemagglutination / Q000276:immunology*; D006402:Hematologic Diseases / Q000097:blood / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D007519:Isoantigens / Q000009:adverse effects / Q000097:blood
D007519:Isoantigens